Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04985630 · ClinicalTrials.gov registry record · NA

The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots

A NA study of Healthy and Healthy Aging, sponsored by Amazentis.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT04985630 is a NA study of Healthy and Healthy Aging that is actively recruiting participants, run by Amazentis. The registered enrollment target is 250 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04985630, a NA study of Healthy and Healthy Aging, is actively recruiting participants, sponsored by Amazentis.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

Open labelled, virtual home based study to assess the test repeatability and the failure/rejection rate of the samples collected at home by participants.

Interventions

  • DIETARY_SUPPLEMENT Mitopure
  • DIETARY_SUPPLEMENT Pomegranate Juice

Study Locations (1)

California

  • Amazentis USA - San Francisco

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2021-08-30
Est. Completion 2026-08-31
Phase NA

Sponsor

Amazentis

5 total trials

What the Registry Record Tells You About NCT04985630

The ClinicalTrials.gov registry entry for NCT04985630 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (61% lower). The listed sponsor is Amazentis, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Mitopure is the first listed.

NCT04985630 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04985630 about?

NCT04985630 is a clinical study titled "The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots". Open labelled, virtual home based study to assess the test repeatability and the failure/rejection rate of the samples collected at home by participants.

What is the current status of trial NCT04985630?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2021-08-30. Estimated completion is 2026-08-31.

What conditions does trial NCT04985630 study?

This clinical trial studies the following conditions: Healthy, Healthy Aging, Healthy Diet.

What interventions are being tested in trial NCT04985630?

The interventions under investigation include: Mitopure (DIETARY_SUPPLEMENT), Pomegranate Juice (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04985630?

This trial is sponsored by Amazentis, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04985630 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.